Login / Signup

Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patients.

Lorenzo G R RomanoLisette M SchütteReinier M van HestKarina MeijerBritta A P Laros-van GorkomLaurens NieuwenhuizenJeroen EikenboomFloor C J I Heubel-MoenenNanda UitslagerMichiel CoppensKarin C J FijnvandraatMariëtte H E DriessensSuzanne PolinderMarjon H CnossenFrank W G LeebeekRon A A MathôtMarieke J H A Kruipnull null
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Peri-operative combination treatment with desmopressin and PK-guided FVIII concentrate dosing in nonsevere haemophilia A is feasible, safe and reduces FVIII consumption.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • combination therapy
  • smoking cessation